About
John Choi has extensive experience as a healthcare investor, executive and serial entrepreneur. In addition to being a co-founder and the CBO of Hua Medicine, he is a Venture Partner with Fidelity. Previous to Hua, he co-founded Pytho Capital, a research-oriented, life-science specialized hedge fund investing in small-cap, public biotech companies. Before co-founding Pytho Capital, John was a Principal at the storied venture capital firm of Venrock Associates, the venture investing arm of the Rockefellers. During his tenure there, John focused on Venrock's biotechnology and medical device franchises, working actively with portfolio companies such as Coley Pharmaceuticals (acquired by Pfizer NYSE:PFE), Sirna Therapeutics (acquired by Merck NYSE: MRK), Celladon Corporation (NASDAQ:CLDN), and Princeton Lightwave. He was also previously involved with investments in Nanogram Devices Corporation (acquired by Wilson Greatbatch NYSE:GB), Targeted Genetics Corporation (NASDAQ:TGEN) and led
Position in the VCSift Database
- • 1 investors hold the Biotechnology, CEO & Co-Founder role in VCSift. John Choi is one of them.
- • 2,641 investors are based in Los Angeles, California, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Los Angeles, US
Contact Information
Find more investors like John
Search Investors